People with allergic fungal rhinosinusitis taking Dupixent (dupilumab) saw significant improvement in congestion and sinus ...

In today’s Healthy Minute, Dr. Kian Azimian will be discussing the differences between a sinus infection and seasonal ...

Facial swelling can stem from allergies, infections, sinus issues or underlying disease.

The FDA approved Dupixent as the first treatment for allergic fungal rhinosinusitis in adults and children over six years old ...

Persistent congestion or sinus pressure in Central Texas? Georgetown ENT explains causes, treatments and when to see a specialist.

Approval in adults and children aged 6 years and older supported by Phase 3 trial demonstrating Dupixent significantly reduced nasal signs and ...

The FDA granted approval to dupilumab for treating patients aged 6 years and up with allergic fungal rhinosinusitis and a history of sino-nasal surgery, marking the first treatment approved for this ...

Researchers at the University of California San Diego and the Veterans Affairs San Diego Healthcare System have identified a distinct biological pattern of chronic rhinosinusitis (CRS), a chronic ...

ENT & Allergy Associates, the nation’s largest ear, nose, throat, allergy, and audiology practice, announced today its decision to implement Epic, a leading electronic health record (EHR), scheduling, ...

The approval makes Dupixent the first FDA-approved therapy for allergic fungal rhinosinusitis, supported by Phase III data showing significant improvements in sinus opacification, nasal symptoms, and ...

US FDA approves Sanofi and Regeneron’s Dupixent for allergic fungal rhinosinusitis: Paris Thursday, February 26, 2026, 15:00 Hrs [IST] The US Food and Drug Administration (FDA) ...

Morning headaches, particularly when combined with loud snoring, dry mouth, or excessive daytime sleepiness, should be ...